ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 239 filers reported holding ISIS PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $343,000 | -11.6% | 5,975 | -1.9% | 0.00% | 0.0% |
| Q1 2015 | $388,000 | +4.9% | 6,093 | +1.4% | 0.00% | 0.0% |
| Q4 2014 | $370,000 | +64.4% | 6,008 | +3.4% | 0.00% | – |
| Q3 2014 | $225,000 | -7.0% | 5,812 | +3.6% | 0.00% | – |
| Q1 2014 | $242,000 | +8.5% | 5,612 | 0.0% | 0.00% | – |
| Q4 2013 | $223,000 | +7.2% | 5,612 | +1.2% | 0.00% | – |
| Q3 2013 | $208,000 | – | 5,547 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 7,202,585 | $270,385,000 | 14.71% |
| DOWLING & YAHNKE LLC | 675,798 | $25,369,000 | 3.98% |
| GARRISON BRADFORD & ASSOCIATES INC | 100,700 | $3,780,000 | 3.87% |
| WILLIAM HARRIS INVESTORS INC | 312,834 | $11,743,000 | 3.67% |
| Meditor Group Ltd | 490,000 | $18,395,000 | 2.59% |
| AVALON CAPITAL MANAGEMENT | 50,943 | $1,912,000 | 1.89% |
| Orinda Asset Management LLC | 14,665 | $551,000 | 1.73% |
| PINNACLE ASSOCIATES LTD | 2,064,760 | $77,511,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 52,850 | $1,984,000 | 1.43% |
| NCM Capital Advisers, Inc. | 24,950 | $937,000 | 1.04% |